Result of General Meeting

09 March 2018

OKYO Pharma Corporation (the “Company”) (AIM: OKYO) is pleased to announce that the resolution put to shareholders of the Company at the general meeting held earlier today was duly passed. Details of the proxy voting will be posted on the Company’s website later today.


For further information contact:


OKYO Pharma Corporation

Willy Simon


+44 (0)20 7382 8300


Beaumont Cornish Limited (Nominated Adviser)

Roland Cornish

Michael Cornish


+44 (0)20 7628 3396


Further information is available on the Company's website:


This announcement is inside information for the purposes of Article 7 of Regulation 596/2014. The person who arranged for the release of this announcement on behalf of the Company was Willy Simon, Director.

Download PDF Version: